A bipartisan group of 28 members of congress, including Senate IP Subcommittee Chair Chris Coons (D-DE), Ranking Member Thom Tillis (R-NC) and House IP Subcommittee Chair Darrell Issa (R-CA), sent a letter yesterday to President Biden urging the administration to reconsider its December proposal to allow agencies to consider pricing in deciding whether and when to “march in” on patent rights. Also yesterday, four bipartisan senators wrote to National Security Advisor Jake Sullivan in opposition to the negotiating text of the World Health Organization (WHO) Pandemic Agreement, warning that it “would undercut—if not destroy—the very aspects of our innovation ecosystem that just recently produced such positive results.”
Recent Posts
- Congress and Courts Need to Look in the Mirror When Asking Why Medical Innovation is Declining
- USPTO Hiring Freeze Ends, Patent Examiners Wanted
- Judiciary Committee Votes Squires Through 20-2
- Disney and Universal Become Latest to Sue Midjourney Over Generative AI Service
- Stewart Says USPTO Wants Early Validity Challenges, Not Late IPRs